Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00064259
Status:
TERMINATED
Last Update Posted:
2021-02-17
First Post:
2003-07-08
Brief Title:
A Phase III Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric Esophageal Junction Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Gastric Cancer |
| Adenocarcinoma of the Esophagus |
| Adenocarcinoma of the Gastroesophageal Junction |
| Diffuse Adenocarcinoma of the Stomach |
| Intestinal Adenocarcinoma of the Stomach |
| Mixed Adenocarcinoma of the Stomach |
| Recurrent Esophageal Cancer |
| Recurrent Gastric Cancer |
| Squamous Cell Carcinoma of the Esophagus |
| Stage III Esophageal Cancer |
| Stage IIIA Gastric Cancer |
| Stage IIIB Gastric Cancer |
| Stage IIIC Gastric Cancer |
| Stage IV Esophageal Cancer |
Keywords: